Quris is a ground-breaking AI Drug Discovery startup, headquartered in TLV and led by a Nobel-laureate, that uses disruptive artificial intelligence together with the world’s first chip-on-chip, high-throughput biology platform to revolutionise drug development by significantly improving the prediction of drugs safety & efficacy prior to clinical trials.

Quris's advisory board and team include world-leading experts in the field of Pharma, Biology and AI. Quris's founders are experienced entrepreneurs with exits and IPOs in their resume.